Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03143894 · ClinicalTrials.gov registry record · NA
Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain Stimulation
A NA study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03143894: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT03143894 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03143894, a NA study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study will test the preliminary efficacy of transcranial direct current stimulation (tDCS) to improve fatigue and cognition in women with a history of breast cancer and persistent fatigue.
Primary Outcome
Change in auditory working memory as measured by the PASAT prior to and following the intervention. PASAT scores range from 0 to 120, with higher scores reflecting better working memory. Larger positive change scores reflect greater improvement in performance from baseline whereas greater negative change scores reflect declines in performance from baseline.
Interventions
- DEVICE tDCS
- OTHER Sham tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-04-21 |
| Est. Completion | 2020-06-24 |
| Phase | NA |
Why NCT03143894 stopped before completion
NCT03143894 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which tDCS is the first listed.
NCT03143894 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03143894 about?
NCT03143894 is a clinical study titled "Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain Stimulation". This study will test the preliminary efficacy of transcranial direct current stimulation (tDCS) to improve fatigue and cognition in women with a history of breast cancer and persistent fatigue.
What is the current status of trial NCT03143894?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2017-04-21. Estimated completion is 2020-06-24.
What interventions are being tested in trial NCT03143894?
The interventions under investigation include: tDCS (DEVICE), Sham tDCS (OTHER).
Who is sponsoring clinical trial NCT03143894?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03143894's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI